{
    "output": [
        [
            "Helix Biopharma Corp.",
            "COMP",
            "Signs",
            "Binding Letter Of Intent",
            "CONCEPT"
        ],
        [
            "Helix Biopharma Corp.",
            "COMP",
            "Develop",
            "New Car-T Technologies",
            "CONCEPT"
        ],
        [
            "Helix Biopharma Corp.",
            "COMP",
            "Focus",
            "Preclinical Work",
            "CONCEPT"
        ],
        [
            "Helix Biopharma Corp.",
            "COMP",
            "Finalization",
            "Collaborative Binding LoI",
            "CONCEPT"
        ],
        [
            "Helix Biopharma Corp.",
            "COMP",
            "Retains",
            "Exclusive License",
            "CONCEPT"
        ],
        [
            "Promab Biotechnologies",
            "COMP",
            "Collaborative Binding LoI",
            "CONCEPT",
            "Helix Biopharma Corp."
        ],
        [
            "Promab Biotechnologies",
            "COMP",
            "Develop",
            "Chimeric Antigen Receptor Car-T",
            "CONCEPT",
            "Helix Biopharma Corp."
        ],
        [
            "Promab Biotechnologies",
            "COMP",
            "Hematological Malignancies",
            "CONCEPT",
            "Helix Biopharma Corp."
        ],
        [
            "Promab Biotechnologies",
            "COMP",
            "Solid Tumours",
            "CONCEPT",
            "Helix Biopharma Corp."
        ]
    ]
}